Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousBlood PlateletsWhole-Body IrradiationBone and BonesPlatelet AggregationAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanPlatelet CountBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsCyclophosphamideHistocompatibilityTransplantation, IsogeneicBone Marrow DiseasesCombined Modality TherapyKidney TransplantationHematopoiesisMice, Inbred C57BLRecurrenceTime FactorsTreatment OutcomeRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationRemission InductionHematologic NeoplasmsImmunosuppressive AgentsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingPlatelet AdhesivenessHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsSurvival AnalysisLeukemia, MyeloidTransplantation ImmunologyRetrospective StudiesGraft vs Host ReactionImmunosuppressionLymphoma, Non-HodgkinStem Cell TransplantationLymphocyte DepletionAcute DiseasePlatelet TransfusionAntineoplastic Combined Chemotherapy ProtocolsLeukocyte TransfusionHeart TransplantationFlow CytometryColony-Forming Units AssayT-LymphocytesSevere Combined ImmunodeficiencyHLA AntigensChimeraSurvival RateMyelodysplastic SyndromesFollow-Up StudiesBreast NeoplasmsMice, Inbred BALB CHematologic DiseasesLung TransplantationActuarial AnalysisCyclosporineCell DifferentiationCell ProliferationBone DensityPlatelet Membrane GlycoproteinsAntineoplastic AgentsDisease-Free SurvivalLymphocyte TransfusionPrognosisNeoplasmsAntibodies, MonoclonalNuclear FamilyCarmustineLeukocyte CountCells, CulturedOrgan TransplantationPancytopeniaEtoposideGraft vs Tumor EffectApoptosisCytarabineGranulocyte Colony-Stimulating FactorGraft vs Leukemia EffectSpleenCell Line, Tumor